ANURAS Overzicht aandelen
Anupam Rasayan India Ltd houdt zich bezig met de aangepaste synthese en productie van speciale chemicaliën in India, Europa, Japan, Singapore, China en Noord-Amerika.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 5/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 1/6 |
Anupam Rasayan India Ltd Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹729.75 |
| 52 Week Hoogtepunt | ₹1,106.30 |
| 52 Week Laag | ₹672.80 |
| Bèta | 0.20 |
| 11 maand verandering | -2.21% |
| 3 maanden verandering | -6.42% |
| 1 Jaar Verandering | -19.52% |
| 33 jaar verandering | -10.38% |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | 38.53% |
Recent nieuws en updates
Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02
Time To Worry? Analysts Just Downgraded Their Anupam Rasayan India Ltd (NSE:ANURAS) Outlook
Aug 24Anupam Rasayan India Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 17Recent updates
Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02Time To Worry? Analysts Just Downgraded Their Anupam Rasayan India Ltd (NSE:ANURAS) Outlook
Aug 24Anupam Rasayan India Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 17Anupam Rasayan India's (NSE:ANURAS) Shareholders Have More To Worry About Than Only Soft Earnings
May 26Analyst Estimates: Here's What Brokers Think Of Anupam Rasayan India Limited (NSE:ANURAS) After Its Full-Year Report
May 22What You Can Learn From Anupam Rasayan India Ltd's (NSE:ANURAS) P/E
Dec 30Anupam Rasayan India (NSE:ANURAS) Might Have The Makings Of A Multi-Bagger
Nov 03Is Now The Time To Put Anupam Rasayan India (NSE:ANURAS) On Your Watchlist?
Jul 13Anupam Rasayan India's (NSE:ANURAS) Returns On Capital Are Heading Higher
Jun 24We Ran A Stock Scan For Earnings Growth And Anupam Rasayan India (NSE:ANURAS) Passed With Ease
Apr 06Earnings Update: Here's Why Analysts Just Lifted Their Anupam Rasayan India Ltd. (NSE:ANURAS) Price Target To ₹988
Jul 28Anupam Rasayan India's (NSE:ANURAS) Promising Earnings May Rest On Soft Foundations
May 20If You Like EPS Growth Then Check Out Anupam Rasayan India (NSE:ANURAS) Before It's Too Late
May 13Returns At Anupam Rasayan India (NSE:ANURAS) Appear To Be Weighed Down
Mar 31Investors Interested In Anupam Rasayan India Limited's (NSE:ANURAS) Earnings
Mar 07Rendement voor aandeelhouders
| ANURAS | IN Chemicals | IN Markt | |
|---|---|---|---|
| 7D | 1.7% | 3.2% | 1.8% |
| 1Y | -19.5% | 22.8% | 36.8% |
Rendement versus industrie: ANURAS underperformed the Indian Chemicals industry which returned 22.8% over the past year.
Rendement versus markt: ANURAS underperformed the Indian Market which returned 36.8% over the past year.
Prijsvolatiliteit
| ANURAS volatility | |
|---|---|
| ANURAS Average Weekly Movement | 2.7% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stabiele aandelenkoers: ANURAS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatiliteit in de loop van de tijd: ANURAS's weekly volatility (3%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1984 | 1,896 | Gopal Agrawal | www.anupamrasayan.com |
Anupam Rasayan India Ltd houdt zich bezig met de aangepaste synthese en productie van speciale chemicaliën in India, Europa, Japan, Singapore, China en Noord-Amerika. Het bedrijf is actief in twee segmenten: Life Science-gerelateerde Specialty Chemicals en Overige Specialty Chemicals. Het bedrijf biedt life science-gerelateerde specialistische chemicaliën, zoals agro-intermediairproducten en agro-actieve ingrediënten voor de agrochemische industrie; antibacteriële en ultravioletbeschermende intermediairproducten en ingrediënten voor de persoonlijke verzorgingsindustrie; en intermediairproducten en belangrijke uitgangsmaterialen voor actieve farmaceutische ingrediënten.
Anupam Rasayan India Ltd Samenvatting
| ANURAS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹80.76b |
| Inkomsten(TTM) | ₹939.16m |
| Inkomsten(TTM) | ₹13.43b |
85.4x
Koers/Winstverhouding6.0x
P/S-verhoudingIs ANURAS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ANURAS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹13.43b |
| Kosten van inkomsten | ₹5.54b |
| Brutowinst | ₹7.89b |
| Overige uitgaven | ₹6.95b |
| Inkomsten | ₹939.16m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 8.55 |
| Brutomarge | 58.78% |
| Nettowinstmarge | 6.99% |
| Schuld/Eigen Vermogen Verhouding | 36.5% |
Hoe presteerde ANURAS op de lange termijn?
Bekijk historische prestaties en vergelijking